DE60232742D1 - Ul16-bindungsprotein 4 - Google Patents

Ul16-bindungsprotein 4

Info

Publication number
DE60232742D1
DE60232742D1 DE60232742T DE60232742T DE60232742D1 DE 60232742 D1 DE60232742 D1 DE 60232742D1 DE 60232742 T DE60232742 T DE 60232742T DE 60232742 T DE60232742 T DE 60232742T DE 60232742 D1 DE60232742 D1 DE 60232742D1
Authority
DE
Germany
Prior art keywords
ulbp4
binding protein
cells
encoding
vectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60232742T
Other languages
German (de)
English (en)
Inventor
David J Cosman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunex Corp
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of DE60232742D1 publication Critical patent/DE60232742D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60232742T 2001-10-04 2002-10-04 Ul16-bindungsprotein 4 Expired - Lifetime DE60232742D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32725201P 2001-10-04 2001-10-04
PCT/US2002/031994 WO2003029436A2 (en) 2001-10-04 2002-10-04 Ul16 binding protein 4

Publications (1)

Publication Number Publication Date
DE60232742D1 true DE60232742D1 (de) 2009-08-06

Family

ID=23275763

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60232742T Expired - Lifetime DE60232742D1 (de) 2001-10-04 2002-10-04 Ul16-bindungsprotein 4

Country Status (10)

Country Link
US (2) US7563450B2 (enExample)
EP (1) EP1451333B1 (enExample)
JP (1) JP2005523681A (enExample)
AT (1) ATE434624T1 (enExample)
AU (1) AU2002340118B2 (enExample)
CA (1) CA2462790A1 (enExample)
DE (1) DE60232742D1 (enExample)
MX (1) MXPA04003057A (enExample)
PL (1) PL373594A1 (enExample)
WO (1) WO2003029436A2 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2483343A1 (en) * 2002-04-22 2003-10-30 Fred Hutchinson Cancer Research Center Soluble mic polypeptides as markers for diagnosis, prognosis and treatment of cancer and autoimmune diseases or conditions
AU2003270063A1 (en) * 2002-09-04 2004-03-29 The Trustees Of The University Of Pennsylvania Immune cell receptor ligand and immune cell receptor
US7666417B2 (en) * 2003-04-22 2010-02-23 Fred Hutchinson Cancer Research Center Methods and compositions for treating autoimmune diseases or conditions
US7834155B2 (en) 2003-07-21 2010-11-16 Immunogen Inc. CA6 antigen-specific cytotoxic conjugate and methods of using the same
EP1660513B9 (en) * 2003-07-21 2012-04-04 ImmunoGen, Inc. A ca6 antigen-specific cytotoxic conjugate and methods of using the same
US7998481B2 (en) 2004-04-05 2011-08-16 The Regents Of The University Of California Modulation of NKG2D for treating or preventing solid organ allograft rejection
DE102004042894A1 (de) * 2004-08-30 2006-03-02 Eberhard-Karls-Universität Tübingen Verwendung von Blockern der NKG2D-Rezeptor-/NKG2D-Liganden-Interaktion bei Autoimmunerkrankungen
CA2587572A1 (en) * 2004-11-24 2006-06-01 Schering Corporation Dap-10 and uses thereof
WO2011130749A2 (en) 2010-04-16 2011-10-20 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Identification of mutations in herpes simplex virus envelope glycoproteins that enable or enhance vector retargeting to novel non-hsv receptors
US20130156808A1 (en) * 2011-11-22 2013-06-20 Stipan Jonjic Vaccine comprising beta-herpesvirus
JP6518199B6 (ja) 2013-03-15 2019-06-12 ノヴェロジックス・バイオテクノロジー，インコーポレーテッド Ｍｉｃａおよびｍｉｃｂタンパク質に対する抗体
JP6588024B2 (ja) 2013-10-28 2019-10-09 ユニヴァーシティ オヴ ピッツバーグ オヴ ザ コモンウェルス システム オヴ ハイアー エデュケーション 腫瘍溶解性ｈｓｖベクター
BR112018015390A2 (pt) 2016-01-27 2018-12-18 Oncorus, Inc. vetores virais oncolíticos e usos dos mesmos
WO2017218689A1 (en) 2016-06-14 2017-12-21 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Expression of nkg2d activating ligand proteins for sensitizing cancer cells to attack by cytotoxic immune cells
WO2018006005A1 (en) 2016-06-30 2018-01-04 Oncorus, Inc. Pseudotyped oncolytic viral delivery of therapeutic polypeptides
AU2017344411A1 (en) 2016-10-19 2019-05-09 Novelogics Biotechnology, Inc. Antibodies to MICA and MICB proteins
WO2019023483A1 (en) 2017-07-26 2019-01-31 Oncorus, Inc. ONCOLYTIC VIRAL VECTORS AND USES THEREOF
US11661447B2 (en) 2017-08-03 2023-05-30 The Cleveland Clinic Foundation Human β2-glycoprotein I expression
US11865081B2 (en) 2017-12-29 2024-01-09 Virogin Biotech Canada Ltd. Oncolytic viral delivery of therapeutic polypeptides
CN112285360B (zh) * 2020-09-23 2023-08-22 台州市第一人民医院 I-309在制备原发性干燥综合征诊断试剂或试剂盒中的应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US22239A (en) * 1858-12-07 Limekiln
US4311A (en) * 1845-12-16 William beebe
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4737462A (en) 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US4518584A (en) 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4965195A (en) 1987-10-26 1990-10-23 Immunex Corp. Interleukin-7
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
WO1990005183A1 (en) 1988-10-31 1990-05-17 Immunex Corporation Interleukin-4 receptors
WO1991018982A1 (en) 1990-06-05 1991-12-12 Immunex Corporation Type ii interleukin-1 receptors
DE4118120A1 (de) 1991-06-03 1992-12-10 Behringwerke Ag Tetravalente bispezifische rezeptoren, ihre herstellung und verwendung
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US20030004311A1 (en) 1997-06-18 2003-01-02 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030022239A1 (en) 1997-06-18 2003-01-30 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
ATE305510T1 (de) 1997-12-17 2005-10-15 Immunex Corp Zelloberflächenglycoproteinen zusammenhang mit menschlicher b zell lymphomen - ulbp, dns und polypeptiden
DE69841110D1 (de) 1997-12-17 2009-10-08 Serono Genetics Inst Sa Verlängerte cdns, die für sekretierte proteine kodieren
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
JP2003505082A (ja) 1999-07-26 2003-02-12 ジェネンテック・インコーポレーテッド 新規なポリヌクレオチドとその使用法
JP2004522404A (ja) 1999-12-01 2004-07-29 ジェネンテック・インコーポレーテッド 分泌及び膜貫通ポリペプチドとそれをコードしている核酸
AU2404001A (en) 2000-01-06 2001-07-16 Protegene Inc. Human proteins having hydrophobic domains and dnas encoding these proteins
US20040219521A1 (en) * 2000-01-21 2004-11-04 Tang Y. Tom Novel nucleic acids and polypeptides
IL151873A0 (en) 2000-03-24 2003-04-10 Micromet Ag Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
WO2001083545A1 (fr) * 2000-04-27 2001-11-08 Takeda Chemical Industries, Ltd. Nouvelle proteine et son utilisation
AU5943201A (en) 2000-05-03 2001-11-12 Amgen Inc Modified peptides as therapeutic agents
WO2002068615A2 (en) 2001-02-28 2002-09-06 Fred Hutchinson Cancer Research Center, Inc. Activation of lymphocyte populations expressing nkg2d using anti-nkg2d antibodies and ligand derivatives
US6821522B2 (en) * 2001-05-31 2004-11-23 The Regents Of The University Of California Tumor Therapy
JP2005502335A (ja) * 2001-08-08 2005-01-27 インサイト・ゲノミックス・インコーポレイテッド 細胞成長、分化および細胞死関連タンパク質
WO2003054152A2 (en) * 2001-12-10 2003-07-03 Nuvelo, Inc. Novel nucleic acids and polypeptides
AU2002238359A1 (en) * 2002-03-04 2003-09-16 Shanghai Genomics, Inc. Tumor tag and the use thereof
AU2003270063A1 (en) * 2002-09-04 2004-03-29 The Trustees Of The University Of Pennsylvania Immune cell receptor ligand and immune cell receptor

Also Published As

Publication number Publication date
US20090274699A1 (en) 2009-11-05
WO2003029436A3 (en) 2003-11-13
US7563450B2 (en) 2009-07-21
JP2005523681A (ja) 2005-08-11
AU2002340118B2 (en) 2007-09-13
ATE434624T1 (de) 2009-07-15
WO2003029436A2 (en) 2003-04-10
MXPA04003057A (es) 2005-06-20
EP1451333A2 (en) 2004-09-01
CA2462790A1 (en) 2003-04-10
PL373594A1 (en) 2005-09-05
US8129167B2 (en) 2012-03-06
EP1451333B1 (en) 2009-06-24
EP1451333A4 (en) 2005-03-30
US20030195337A1 (en) 2003-10-16

Similar Documents

Publication Publication Date Title
ATE434624T1 (de) Ul16-bindungsprotein 4
ATE454393T1 (de) Egvii-endoglucanase und dafür codierende nukleinsäuren
HU9601448D0 (en) Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
IL210454A0 (en) Novel cytokine zcytor17 ligand
WO2003020756A3 (en) Hybrid and tandem expression of neisserial proteins
AU2656595A (en) Purified myceliophthora laccases and nucleic acids encoding same
AU2002217010A1 (en) Peptides, the production and use thereof for binding immunoglobulins
WO2004043403A3 (en) Synthetic single domain polypeptides mimicking apolipoprotein e and methods of use
WO2004035618A3 (en) Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof
DE69937570D1 (de) Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
EP0816504A3 (en) Platelet activating factor acetylhdrolase, and gene thereof
DE69619808D1 (de) Chimäre msp und daf proteine mit einem telloberflächenlokalisierendem domän
AU4375493A (en) Isolated protein receptors, antibodies which bind thereto, nucleic acid sequence coding therefor, and uses thereof
CY1111763T1 (el) ΑΝΤΙΣΩΜΑΤΑ ΕΝΑΝΤΙΟΝ ΤΗΣ ΠΡΩΤΕΪΝΗΣ p51
IL139604A (en) Fibrinogen-beta chain derived peptide, compositions comprising same and use thereof
AU3711597A (en) A novel galanin receptor
AU2003264535A1 (en) Tumor antigen protein and utilization thereof
WO2001068846A3 (en) Transcription activator of the cited family
CA2199403A1 (en) Novel PKA-Binding Proteins and Uses Thereof
WO2003091447A3 (en) D1-1 nucleic acids, polypeptides and related methods
ATE410513T1 (de) 'patched-2' protein aus wirbeltieren
MXPA01011563A (es) Una novedosa proteina 5 relacionada al factro-h y anticuerpos relacionados.
SE0101519D0 (sv) Nucleic ACID
WO2003018806A1 (fr) Nouveau gene humain bmcc1

Legal Events

Date Code Title Description
8364 No opposition during term of opposition